Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first ...

The MHRA has granted marketing authorisation for Eylea® (aflibercept 8 mg) for the treatment of patients with macular oedema following retinal vein occlusion (RVO) including branch, central and ...

A newly published study found that intravitreal injection of autologous CD34+ stem cells is well tolerated and feasible for treating loss of vision resulting from central retinal vein occlusion (CRVO) ...

Learn about central retinal vein occlusion (CRVO), its causes, symptoms, diagnosis, and treatment options for vision loss.

Former Pakistan Prime Minister Imran Khan was taken from Adiala Jail to the Pakistan Institute of Medical Sciences (PIMS) shortly after midnight on Tuesday for a scheduled eye procedure and cardiac ...

Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of Eylea (aflibercept 8mg, 114.3 ...

Age related macular degeneration is diagnosed through eye examination. Ophthalmologists use retinal imaging and optical ...

Cigarette smoke accelerates eye aging by causing epigenetic changes that block the eye's natural repair genes.

Sentinel participant showed OPGx-BEST1 was well tolerated with no ocular inflammation, treatment-related adverse events, or ...

London, UK – Biologic Innovation to Drive Global Ophthalmic Drugs Market Growth at 7.9% CAGR Through 2036 says Visiongain, in the newly released report entitled Ophthalmic Drugs Market Report ...

Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...